Over the past 20 years, significant advancements in stem cell research and therapies have been one of the most promising methods of creating new insulin making cells needed to cure type 1 diabetes. Vertex Pharmaceuticals, a biotech company, recently began a clinical trial where it plans to treat 17 participants who have type 1 diabetes with new stem cell derived insulin making cells.
- The first patient in the trial has had positive results.
- Other companies around the world including ViaCyte and CRISPR, as well as Novo Nordisk, one of the biggest insulin manufacturers in the world, are also working on curing the disease.
- CNBC explores why finding a cure for diabetes is so hard and just how close Vertex and other companies are to solving this problem.
Mon, 21 Mar 2022 16:00:07 GMT Sign Up for Our Newsletter Daily Update Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Get this delivered to your inbox, and more info about about our products and services.
Will they ever find a cure for diabetes?
Diabetes: Will It Ever Be Cured? While the end to diabetes is still in the distant future, strides in genetic research are showing promise. Immunology and beta cell function have long been two core areas of research in the hunt for a cure for diabetes.
Why can’t we cure type 2 diabetes?
We talk of remission and not a cure because it isn’t permanent. The beta cells have been damaged and the underlying genetic factors contributing to the person’s susceptibility to diabetes remain intact. Over time the disease process reasserts itself and continued destruction of the beta cells ensues.
What is the miracle cure for diabetes?
Miracle cure for diabetes is a fraud that could cheat you of time, money and most importantly, your health. There are many scams designed to prey on consumers with diabetes who are hoping to find solutions to living with this chronic disease.
Is there any chance to reverse diabetes?
How can I lose weight? – Some people have lost a substantial amount of weight and put their diabetes into remission through lifestyle and diet changes or by having weight loss surgery (called bariatric surgery). There is no such thing as a special diet for people with diabetes or those aiming or diabetes reversal.
Why diabetes will come?
The role of glucose – Glucose — a sugar — is a source of energy for the cells that make up muscles and other tissues.
Glucose comes from two major sources: food and the liver. Sugar is absorbed into the bloodstream, where it enters cells with the help of insulin. The liver stores and makes glucose. When glucose levels are low, such as when you haven’t eaten in a while, the liver breaks down stored glycogen into glucose. This keeps your glucose level within a typical range.
The exact cause of most types of diabetes is unknown. In all cases, sugar builds up in the bloodstream. This is because the pancreas doesn’t produce enough insulin. Both type 1 and type 2 diabetes may be caused by a combination of genetic or environmental factors. It is unclear what those factors may be.
Why can’t type 1 diabetics get a pancreas transplant?
Should You Get a Pancreas Transplant for Type 1 Diabetes? Announcer: Interesting, informative and all in the name of better health. This is The Scope Health Sciences Radio. Interviewer: A lot of people with Type 1 diabetes believe that the insulin shots and a pump is enough, but there might actually be a better option, a pancreas transplant.
We’re with Dr. Paul Campsen, Surgical Director of Pancreas Transplant Surgery with the University of Utah. That option is pancreatic surgery. Dr. Paul Campsen: That’s correct. Right now we do pancreas transplants for Type 1 diabetics. Type 1 diabetics can’t survive without insulin, so they give themselves shots and they can administer this sometimes through am insulin pump which is a very good way to keep them alive.
The control that they get from that is not a replacement for the human organ, the pancreas. That’s where the pancreas transplant comes into play in the sense that you can help yourself stay alive just like dialysis helps with kidney transplant, or with failure.
- A pancreas transplant gives you back the human organ that you actually need.
- Interviewer: Plus, also a better quality of life. Dr.
- Paul Campsen: A much better quality of life.
- Over the long term the pancreas transplant itself is completely correcting the diabetes, so any of the sequelae of diabetes, whether it be peripheral vascular disease, damage to your eyes, damage to your nerves, damage to your coronary arteries, all of that stuff is stopped with a pancreas transplant.
Interviewer: Not with the insulin shots or the pump? Dr. Paul Campsen: No, I think that the insulin helps a lot. It slows down the damage. Obviously it literally saves their lives by giving them insulin, but it doesn’t stop the diabetes because you’re still a diabetic.
- The pancreas produces a variety of different enzymes and secretes many things that actually help the body including insulin, also glucagon, which keeps the sugars from going too low which can be life threatening, and any of the pancreatic enzymes that help with digestion.
- None of that’ s given with the insulin pump.
When you replace the pump with a human pancreas you get all of those benefits. Interviewer: It sounds like a great solution. Why aren’t more people doing it? Is it a dangerous surgery or is it fairly safe? Dr. Paul Campsen: The diabetics who come to us hate their diabetes so much and they’re so scared by it, and their so scared by brittleness of their, meaning they go too high with their sugar or too low, that they would do almost anything not to have to use insulin anymore, but they’re scared because surgery is a big deal.
- The vast majority do very well with this surgery.
- It’s very safe.
- They stay in the hospital for about a week afterwards, but the moment that they leave surgery they’re not a diabetic anymore.
- Interviewer: That’s pretty amazing, isn’t it? Dr.
- Paul Campsen: It is pretty amazing.
- Many of the patients that come to us, their diabetes has also ruined their kidneys, so they’re on dialysis at the same time.
We’ll do a simultaneous pancreas and kidney transplant. The moment that they leave the surgery the next morning they’re cured of their diabetes and they’re cured of the their renal failure and they’re not on dialysis. The other thing that’s very interesting in these patients is if you just give them a kidney transplant their Type 1 diabetes will still attack the kidney transplant.
- Interviewer: It just kills that organ. Dr.
- Paul Campsen: That’s exactly right.
- The pancreas transplant added on top, because it cures the diabetes, actually protects the kidney transplant.
- Then both organs survive much longer.
- Interviewer: Who would be a good candidate for this type of surgery? Dr.
- Paul Campsen: I think anybody who has Type 1 diabetes.
We’re talking about unfortunate people who were diagnosed with diabetes probably before they were 20. We’d like to see these patients well before they get into their 30’s. The earlier we see them the better. Interviewer: OK. What are your final thoughts for somebody that has Type 1 diabetes and is a little on the fence? Dr.
- Paul Campsen: I think basically this is a safe surgery.
- Coming and seeing us doesn’t mean we’re going to trap you and give you the surgery, but it’s something where we can talk about it and see if this is the right surgery for you.
- If it is, we can cure your diabetes.
- If you have kidney problems we’ll take care of those too.
Announcer: We’re your daily dose of science, conversation and medicine. This is The Scope University of Utah Health Sciences Radio. : Should You Get a Pancreas Transplant for Type 1 Diabetes?
Can stem cells cure diabetes type 2?
Are stem cells FDA approved for Type 2 Diabetes? – The FDA has not approved stem cell therapy for type 2 diabetes. As noted above, studies have demonstrated the safety and efficacy of stem cell therapy for this condition but additional studies are needed before FDA approval can be secured.
How long can you reverse diabetes?
How long does it take to reverse diabetes? – There’s no set timeframe for when people with Type 2 diabetes may start to see their hard work pay off. In general, diabetes experts say with medication and lifestyle changes, diabetes patients could notice a difference in three to six months,
It may take one month to stabilize blood sugar (with or without medication), and then a couple of months or more for lifestyle changes to take effect. “With enough work and time, you can do it,” says Stephanie Redmond, Pharm.D., CDE, BC-ADM, co-founder of diabetesdoctor.com, “The longer you’ve had diabetes and the higher your sugars have been for a sustained time, the harder this might be.” Redmond adds that despite their best efforts, it may be impossible for some to become diabetes-free.
“Your pancreas just can’t produce the insulin it needs. There’s no point in stressing or beating yourself up. Work with your healthcare provider on the best medication plan for you.” An A1C test measures average blood sugar levels (hemoglobin a1c) over the previous two to three months.
- A hemoglobin A1C below 5.7% is normal, between 5.7 and 6.4% is a sign of prediabetes, and 6.5% or higher indicates diabetes.
- People managing their Type 2 diabetes should get an A1C test at least two times a year and more often if they change medications or have other health conditions.
- People working to reverse diabetes may see a difference in their blood sugar right away and be tempted to go back to their old ways.
“Don’t confuse this,” Redmond says. “If you stop eating sugar and carbs and exercising, you may have lower or normal blood sugars almost immediately. But, it may take much longer to reverse the damage that the pancreas has endured and start to cut through the body’s insulin resistance and inflammatory state.” Reversed diabetes can return.
Will cutting out sugar reverse diabetes?
Treating diabetes – Treatment for diabetes starts with reducing kapha aggravating foods, to balance kapha dosha. We want to remove heavy oily foods from the diet – that means avoiding dairy and refined carbohydrates such as bread, pasta, pizza, bread rolls, potatoes, rice, cakes and biscuits and just going for small amounts of healthy oils.
Instead its important to eat plenty of warm, nourishing foods. Other foods to watch out for are bananas, figs, dates, barley, millet, corn, rye, oats and rice; wheat is definitely out. Beans are good, aside from soya beans (tofu is out, but tempe is good). Spices are preferable than pepper as it stimulates movement.
Drinking lots of ginger water will also help by stimulating the (the digestive fire). Movement is really important in getting the circulation going. This helps lower blood glucose levels and improves the body’s overall functioning. Yoga is wonderful for people with diabetes, in particular the sun salutation gets the blood moving as it should.
Home remedy: bitter lemon juice Combine fenugreek, cinnamon, turmeric with fresh squeezed bitter lemon (like a cucumber with bubbles) and drink a 50ml shot every morning – this is excellent for lowering glucose. If you can get bitter melon you can make this into a 30 ml shot and take every morning.
: Stopping sugar alone won’t reverse your diabetes, here’s what you need to do instead
Has type 1 diabetes ever been reversed?
Ask the Doctors
Dear Doctors: As someone who was born with Type 1 diabetes, I’m very interested in any new advances that make it easier to live with this disease. I’ve recently heard on the news that someone has actually been cured. Is that possible? Is there going to be a treatment soon? Dear Reader: You’re referring to the release of preliminary data from a clinical trial that is testing a potential cure for Type 1 diabetes.
The trial is quite small – just 17 participants – and the initial result concerns only one person. However, the outcome is so remarkable, it’s making international news. According to the Massachusetts-based pharmaceutical company conducting the trial, the first participant has not only decreased his daily insulin use by 91%, but for the first time in his life, his body is producing insulin in response to blood sugar fluctuation.
For those who are not familiar with Type 1 diabetes, it’s an autoimmune disease. This occurs when the immune system malfunctions and mistakenly attacks and damages the body’s own tissues. In Type 1 diabetes, certain white blood cells attack and destroy the clusters of specialized cells in the pancreas known as islets, which produce insulin.
- Without insulin, the cells of the body can’t access blood sugar, which is one of the products of digestion.
- Not only does this leave cells without their main source of energy, but it results in an uncontrolled buildup of glucose in the blood, which is extremely dangerous.
- Eeping blood sugar within a healthful range when you have Type 1 diabetes requires constant testing, daily insulin and a carefully controlled diet.
Even so, people living with the disease are at increased risk of a range of adverse health effects, including heart attack, stroke and nerve impairment. The disease is the leading cause of blindness and kidney failure in the United States. 
Elizabeth Ko, MD and Eve Glazier, MD The only known cure for Type 1 diabetes is either a pancreas transplant or a transplant of the specialized pancreatic cells that produce insulin. But with a shortage of available organs and 1.6 million people in the U.S.
living with the disease, a cure for the vast majority is not possible. That’s what makes the positive results in this clinical trial such big news. The first participant, who is 64, has been living with Type 1 diabetes for nearly 50 years. His disease is so severe, he regularly experienced sudden drops in blood sugar that caused him to lose consciousness.
A few days after receiving an infusion of stem cells that have been “taught” how to behave like islets, everything changed. His blood sugar readings were in the normal range. Even after eating a meal, which requires the body to secrete insulin in order to manage blood glucose, his readings remained perfect.
If this first participant continues to respond to ongoing treatment, his will be the first-ever functional cure of diabetes. It’s a thrilling – but also very early – result. There are 16 more participants in the clinical trial, and five years left to go. Whether or not the man continues to respond to treatment, and whether or not the results can be duplicated in other patients, remains to be seen.
At UCLA Health, our Division of Endocrinology, Diabetes and Metabolism consistently ranks among the top programs of its kind in the nation. Learn more and schedule your appointment. (Send your questions to [email protected], or write: Ask the Doctors, c/o UCLA Health Sciences Media Relations, 10960 Wilshire Blvd., Suite 1955, Los Angeles, CA, 90024. 
I am 75 years old, and two years ago, I was diagnosed with bullous pemphigoid. I understand this is an autoimmune problem. I also understand that this is more common in older people. I would like to know more about it. I have been prescribed minocycline, which has been helping. 
I’ve been reading that it’s a pretty bad flu season this year, and I’m starting to get worried about getting sick. I haven’t gotten a flu shot yet, but I think it might be too late. Is it still worthwhile to get the vaccine? Is this year’s vaccine effective? 
I’m having my first colonoscopy in a few months. My friends say it’s unpleasant, and I’m already dreading it. I think it would help if I knew what’s going to happen. How often do you need to get a colonoscopy? And is there any way around having to use that prep drink?
Can diabetes 1 go into remission?
Discussion and review – In the adult population (defined by many studies as >15 years age or after puberty), complete remission was noted to be more common than in the paediatric population. Based on the studies on the adult population, incidence of partial remission was seen in 3–61% of newly diagnosed T1D. Complete remission incidence rates ranged between 0 and 20% at 6 months and 0 and 10% at 12 months after the initiation of insulin therapy in a newly diagnosed T1D ( 12 – 21 ). Guastamacchia et al. ( 18 ) noted a complete remission of 61%; however, the patients in this study were treated with continuous subcutaneous insulin infusion for management of T1DM. Martin et al.16 showed that higher rates of spontaneous clinical remission occur during the 1st year after diagnosis. Highest incidence rates have been noted around 6 months after initial diagnosis ( 21 ). Patients with limited damage to beta cells at the time of T1DM diagnosis portended a higher chance of incidence of remission ( 21 ). Selam et al. ( 19 ) observed that patients initially treated with insulin followed by glipizide had higher rates of remission compared to insulin treatment alone. In the adult population, Agner et al. ( 13 ) and Martin et al. ( 16 ) suggested various factors that were positively correlated with remission rates. These included high BMI, normal serum bicarbonate level at T1DM onset, mild hyperglycemia, and relatively higher fasting C-peptide levels. Although the definition of complete remission used in the above-mentioned studies was slightly different, only those studies were included in this review article that defined complete remission as a euglycemic state (HbA1C<6) without being on insulin or other anti-diabetic medications for a minimum of 2 weeks duration. In the paediatric population, frequency of partial remission has been documented to be 25–100% ( 16 ) and the range for duration of this partial remission was 1 month to 13 years ( 22 ). This range holds true for the adult population as well. Most studies show that maximal remission is achieved 3 months after initial diagnosis and insulin therapy ( 7 ). Total/complete remission is extremely rare in newly diagnosed T1DM children and adolescents ( 7, 16, 22 – 24 ). Partial remission is however seen more commonly ( 25, 26 ). Any relationship between age of onset of T1DM and incidence rate of remission is controversial. Abdul-Rasoul et al. ( 7 ) and Drash et al. ( 27 ) noticed that partial remission was higher in older children (5–15 years) in a study population age ranging 0–15 years. A few studies ( 25, 28 ) noted that there is no correlation between rate of remission and age of onset of DM1. Bober et al. ( 26 ) noted that remission rate was higher in 2–5 year age group compared to that of 6–12 year age group. Relationship between sex and rate of remission is also controversial. Multiple studies ( 7, 29 – 32 ) showed no relation; however, Schiffrein et al. ( 33 ) mentioned that girls may have better remission rates compared to boys. On the contrary, Pollizzi et al. ( 32 ) reported that males may have increased remission rates and longer duration of remission compared to females. Severity of metabolic de-compensation at the time of initial diagnosis of T1DM (patients presenting with DKA vs. patient not presenting with DKA) appears to have a significant negative correlation with the time of onset of remission and the duration of remission ( 7, 26, 31, 34, 35 ). In the paediatric population, reported incidence of complete remission is around 0–3.2% ( 7, 16, 36 ) HbA1C levels at the time of T1DM diagnosis and duration of symptoms of T1DM has a negative correlation with the length of remission ( 13, 17, 37 – 41 ). Three studies ( 42 – 44 ) suggested that new-onset T1DM patients that were managed with intensive insulin management showed higher remission rates. The mechanism for this improved remission rates in patients that are managed with intensive insulin therapy is not clearly understood. Extensive research is currently being conducted on type 1 diabetics to innovate ways to prevent or reverse this condition. Treatment with immune-modulators and immunosuppressive agents given to a newly diagnosed T1D has been studied only in small uncontrolled studies. Although interesting results were derived, definitive conclusions could not be made from them ( 45 ). Cyclosporine, azathioprine, GAD 65 immunotherapy, anti-CD3 antibodies, rituximab, mycophenolate mofetil, thymoglobulin, bacillus calmette-guerin, TNF alpha inhibitors, interferon alpha, nicotinamide, and Vitamin D supplements are just a few examples of drugs that are being studied to alter the course of T1DM. Details of individual study results regarding the above-mentioned interventions are vast and beyond the scope for this review article. The study by Rewers et al. ( 45 ) focuses on the details of these trials and immune-modulator interventions. Further ongoing bench research should hopefully provide us with better answers in understanding the patho-physiology and management of T1DM.